Atom Medical

What Atom Medical does

Atom Medical Corporation (アトムメディカル株式会社) is a privately held Japanese specialty medical-device manufacturer headquartered in Bunkyo-ku, Tokyo, specializing in perinatal and neonatal care equipment. The company traces its origin to 1952, when it developed Japan's first modern infant incubator, and operates across neonatal incubators (notably the Ai7 launched in November 2025 with its proprietary Thermo Pairing® thermal regulation and sub-39 dB noise design), fetal monitoring transducers and spiral scalp electrodes compatible with Philips systems, delivery and examination tables, LED phototherapy (Bilitherapy), procedure lamps, transport incubators, and a comprehensive consumables portfolio spanning oxygen nasal cannulae, reservoir cannulae, open-face masks, enteral feeding catheters, and uterine hemostatic balloons marketed under the Respiall brand. Atom Medical is registered as a marketing authorization holder in Japan for numerous PMDA-approved devices and maintains ISO 80369-3 small-bore connector compliance across its enteral consumables.

The company sells primarily through a direct enterprise field-sales force to hospital NICUs, perinatal centers, and obstetric/gynecological departments in Japan, supported by two product showrooms (Tokyo and Osaka) and a clinician-only member portal (launched July 2024). Revenue is generated through capital equipment sales (incubators, monitors, tables), recurring consumables, annual maintenance service contracts, paid professional education (workshops and seminars such as the DC Seminar and Fetal Monitoring Workshop), and — following the October 15, 2025 acquisition of Melody International — subscription-based mobile/cloud fetal monitoring (iCTG). Atom Medical is expanding its footprint through the recently incorporated Italian entity ATOM MEDICAL EUROPE S.R.L. (effective October 1, 2025), wholly owned subsidiary Atom Medical Hu'Care Inc. (respiratory care, November 2022), Philippines-based manufacturing subsidiary ATOMED CEBU, INC., and group company Life Med Co., Ltd. The company's stated philosophy is "to save a tiny baby life," and it is led by President & Representative Director Ichiro Matsubara (松原 一郎).

Name

Atom Medical

Legal name

アトムメディカル株式会社

Website

https://atomed.co.jp

Company type

Private

Founded year

1952

Operating status

Operating

Headcount range

11–50 employees

Short description

Atom Medical Corporation is a privately held Japanese specialty medical-device manufacturer, founded in 1952 as the developer of Japan's first modern infant incubator, that produces neonatal incubators, fetal monitoring consumables, obstetric/gynecological devices, and respiratory care products sold primarily to hospital NICUs and perinatal centers in Japan.

Ownership category

akta.pro rank

Product category

Neonatal & Perinatal Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neonatal Intensive Care & Special Care Nurseries (NICU/SCN) (HLAFAJAE)

Keywords

• Neonatal incubator systems
• Perinatal medical devices
• Obstetric monitoring equipment
• Oxygen therapy consumables
• Disposable medical products

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Neonatal incubator hardware sales: Capital equipment sales of infant incubators (including the Ai7 launched October 2025) to hospital NICUs and perinatal centers.
2. Obstetric and gynecological device sales: Sales of fetal monitoring transducers, scalp electrodes, delivery tables, examination tables, and uterine hemostatic balloon devices.
3. Medical consumable sales: Recurring revenue from disposable products such as oxygen nasal cannulas, reservoir cannulas, extension tubes, nutrition catheters, open face masks, and bilirubin meter spot components.
4. Maintenance service contracts: Annual maintenance plans covering incubators, fetal monitors, examination/delivery tables, and laboratory analyzers, including inspection deliveries.
5. Subscription-based cloud CTG (via Melody International): Recurring subscription revenue from Melody International's mobile/cloud-based fetal monitoring (iCTG) platform integrated into the group following the 2025-10-15 acquisition.
6. Professional education fees: Paid workshops and seminars (e.g., DC Seminar 13,000 yen in 2021, hands-on workshops 15,000 yen doctors / 10,000 yen nurses) for clinicians.

Pricing tiers

Go-to-market motion5 records

Core offering

Atom Medical manufactures and sells medical devices and disposables for perinatal, neonatal, obstetric, gynecological, and nursing care in Japan and selected international markets. Its portfolio spans neonatal incubators (Ai7 / Ai7 Wide Dual), LED phototherapy units, infant warmers, fetal monitoring transducers and scalp electrodes, delivery and examination tables, uterine hemostatic balloon devices, point-of-care fibrinogen testing, surgical instruments, and a consumables line that includes oxygen nasal cannulas, reservoir cannulas, open face masks, oxygen face masks with reservoir bags, enteral feeding catheters, and oxygen supply tubing.

Differentiator

Problem solved

Functional benefit

Brands

• Respiall (レスピオール): Atom Medical's respiratory-care product brand covering oxygen nasal cannulae, reservoir cannulae, open-face masks, oxygen face masks with reservoir bag, and related accessories. Launched historically from the 1972 launch of the Atom Oxygen Nasal Cannula OX-20 and reorganized into the Respiall brand around 2021–2023.

Products and services

• Atom Incubator Ai7 (アトム保育器 Ai7)
• Atom Incubator Ai7 Wide Dual (アトム保育器 Ai7 ワイド デュアル)

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Drägerwerk: German global leader in neonatal care, offering the Babyleo and Isolette incubator lines, infant warmers, and phototherapy devices. Dräger is the most direct global competitor to Atom Medical's neonatal incubator franchise.
• GE HealthCare: Sells the Giraffe OmniBed, Giraffe Incubator Carestation, and Panda iRes warmer families to NICUs worldwide, directly competing with Atom's Ai7 and i-series incubators across both domestic and international accounts.
• Philips: Major manufacturer of Avalon fetal/maternal monitors and obstetrics ultrasound transducers. Atom distributes Philips-compatible consumables (transducers, spiral scalp electrodes) and competes with Philips in CTG/fetal monitoring alongside the newly acquired Melody International platform.
• Fisher & Paykel Healthcare: New Zealand-based leader in respiratory care and neonatal humidification, with strong overlap to Atom's Respiall oxygen-therapy line and consumables (nasal cannulas, masks). Comparable business model of capital hardware plus recurring consumables.
• Natus Medical: US-based specialist in neonatal neurology (EEG/CFM monitors — directly relevant to Atom's CFM-OBM offering), hearing screening, and newborn care, with overlapping perinatal/neonatal device categories.
• Huntleigh Healthcare (Arjo): Specialist in fetal monitoring (Sonicaid range) and obstetric ultrasound, overlapping with Atom's CTG and OB device categories, particularly relevant for international accounts.
• Atom Medical Hu'Care (respiratory brand): Listed here as a peer rather than subsidiary to highlight Respiall's direct competitive set against specialized oxygen-therapy brands like Salter Labs and Westmed, since Respiall operates as a distinct respiratory-care brand within the group.

Emerging players

• Mindray: Chinese medical device maker with growing presence in patient monitoring, obstetrics, and neonatal care. Competes with Atom in fetal monitoring and across APAC emerging markets.

Broad incumbents

• Nihon Kohden: Largest Japanese medical electronics company, dominant in patient monitoring including perinatal/neonatal. Provides an established domestic incumbent benchmark against Atom's specialty perinatal franchise.
• Medtronic: Global medtech incumbent offering enteral feeding (e.g., Kangaroo), respiratory, and patient monitoring products. Competes with Atom in enteral consumables and broader perinatal care categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atom Medical